Anondita Medicare IPO Soars on Debut, Lists at ₹275 on NSE Emerge
By Shishta Dutta | Updated at: Sep 15, 2025 04:24 PM IST

New Delhi, September 1, 2025 -Anondita Medicare Limited shares debuted as a blockbuster on the NSE Emerge platform today, listing at ₹275 per share, 89.65% premium over the IPO price of ₹145.
The stock listed at ₹275.50 and had an intraday high of ₹288.00 in minutes of listing, before weakening to ₹262.50 as of 10:05 AM. Despite the initial weakness, the listing brought robust gains for investors, indicating the huge subscription interest Anondita Medicare IPO had received.
Key Listing Day Data (as of 10:05 AM, Sept 1, 2025)
Anondita Medicare opened strongly on the bourses today. At an issue price of ₹145 per share, the stock opened at ₹275, a fat 89.65% premium. It opened marginally higher at ₹275.50 and hit an intraday peak of ₹288.00, before moving down to a low of ₹262.50, which was also the last price traded till 10:05 AM. The share saw active action, with 21.47 lakh shares traded, worth a turnover of approximately ₹59.21 crore, making the company’s market capitalization stand at almost ₹482.91 crore on the listing day.
IPO Recap
The ₹69 crore IPO of Anondita Medicare, which opened on August 22-26, 2025, was a galloping success, subscribed 277.37 times. The demand came led by retail investors at 286.12 times, followed by NIIs at 248.32 times, and QIBs at 153 times.
Anchor investors Vikasa India EIF I Fund, SageOne Flagship Growth OE Fund, Cognizant Capital Dynamic Opportunities Fund, Minerva Ventures Fund, and Pine Oak Global Fund were allocated 13.5 lakh shares at ₹145 per share before the IPO.
Anondita Medicare Limited, established in 1990, produces and sells sexual wellness products under its brand name “COBRA.” With an installed capacity of 562 million condoms per annum, the company supplies to both domestic and export markets, aided by state-of-the-art quality systems and certifications.
REF: https://www.nseindia.com/get-quotes/equity?symbol=ANONDITA
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations

